|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Cash flows provided by (used in) operating activities: | ||||
| Net increase (decrease) in net assets resulting from operations | ||||
| Adjustments to reconcile net increase in net assets resulting from operations to net cash provided by (used in) operating activities: | ||||
| Purchases of investments | ||||
| Fundings assigned to Adviser Funds | ||||
| Principal and fee repayments received | ||||
| Proceeds from the sale of debt investments | ||||
| Proceeds from the sale of equity and warrant investments | ||||
| Net change in unrealized (appreciation) depreciation | ||||
| Net realized (gain) loss | ||||
| Payments for derivative instruments | ||||
| Accretion of paid-in-kind interest | ||||
| Accretion of loan discounts | ||||
| Total accretion of loan discounts | ||||
| Accretion of loan discount on convertible notes | ||||
| Loss on extinguishment of debt | ||||
| Accretion of loan exit fees | ||||
| Change in loan income, net of collections | ||||
| Unearned fees related to unfunded commitments | ||||
| Amortization of debt fees and issuance costs | ||||
| Depreciation and amortization | ||||
| Stock-based compensation and amortization of restricted stock grants | ||||
| Change in operating assets and liabilities: | ||||
| Interest receivable | ||||
| Other assets | ||||
| Accrued liabilities | ||||
| Net cash provided by (used in) operating activities | ||||
| Cash flows provided by (used in) investing activities: | ||||
| Purchases of capital equipment | ||||
| Net cash provided by (used in) investing activities | ||||
| Cash flows provided by (used in) financing activities: | ||||
| Issuance of common stock | ||||
| Offering expenses | ||||
| Retirement of employee shares, net | ||||
| Distributions paid | ||||
| Issuance of debt | ||||
| Repayment of debt | ||||
| Debt issuance costs | ||||
| Fees paid for credit facilities | ||||
| Net cash provided by (used in) financing activities | ||||
| Net increase (decrease) in cash, cash equivalents, foreign cash and restricted cash | ||||
| Cash, cash equivalents, foreign cash and restricted cash at beginning of period | ||||
| Cash, cash equivalents, foreign cash and restricted cash at end of period | ||||
| Supplemental disclosures of cash flow information and non-cash investing and financing activities: | ||||
| Interest paid | ||||
| Income tax, including excise tax, paid | ||||
| Distributions reinvested | ||||
Loading...
